AMRN: 阿玛琳

AMRN新闻

• 14:47 Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate
• 14:20 DYN Stock Rises 19.2% in 3 Months: What's Driving the Rally?
• 13:26 ZNTL Stock Rises 28% in 3 Months: What's Driving the Rally?
• 14:19 GSK Discontinues Development of Camlipixant for Refractory Chronic Cough
• 16:24 Here's Why You Should Add INKT Stock to Your Portfolio Now
• 16:04 AZN Inks Deal With Dizal to In-License Rights to Lung Cancer Drug
• 13:40 Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year?
• 12:48 Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal
• 15:08 FDA Expands MRK & PFE's Keytruda-Padcev Combo Use in Bladder Cancer
• 13:03 CG Oncology Stock Gains 12% in Three Months: What's Driving It?
• 14:40 Immunome Stock Up 32% in a Month: Here's What You Should Know
• 14:18 FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data
• 13:55 Bears are Losing Control Over Amarin (AMRN), Here's Why It's a 'Buy' Now
• 18:26 United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know
• 14:52 TVRD Stock Rallies 149% So Far This Week: Here's What You Should Know
• 14:32 AGIO's Filing for Mitapivat in SCD Gets FDA's Priority Tag, Stock Up
• 14:15 ZTS Wins European Commission Approval for New Poultry Disease Vaccine
• 15:12 EU Approves Expanded Use of ABBV's Tepkinly in Follicular Lymphoma
• 12:58 TG Therapeutics Begins Phase II Study With Briumvi in Schizophrenia
• 12:58 Amarin: The Market Is Pricing A 55% Chance Of A Sale That Isn't Coming (NASDAQ:AMRN)
• 14:45 Reasons Why Investors Should Consider Betting on Neurocrine Stock
• 12:55 UTHR Strengthens Regenerative Medicine Platform With Thymmune Deal
• 13:32 PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare
• 14:41 Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why